AWGLSCP
MDVL

ABG-WTT Global Life Science Capital Partners’s MedAvail Holdings, Inc. Common Stock MDVL Stock Holding History

ABG-WTT Global Life Science Capital Partners’s Portfolio MDVL Stock Details MDVL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-300,588
Closed -$1.35M – 5
2023
Q4 		$1.35M Hold
300,588
– – 2.63% 2
2023
Q3 		$1.8M Sell
300,588
-2
-0% -$21 8.65% 2
2023
Q2 		$3.68M Hold
300,590
– – 66.84% 1
2023
Q1 		$4.31M Hold
300,590
– – 67.93% 1
2022
Q4 		$4.51M Hold
300,590
– – 72.83% 1
2022
Q3 		$11.7M Hold
300,590
– – 72.8% 1
2022
Q2 		$23M Buy
300,590
+222,871
+287% +$19.6M 81.12% 1
2022
Q1 		$3.77M Hold
77,719
– – 30.64% 2
2021
Q4 		$5.44M Hold
77,719
– – 73.8% 1
2021
Q3 		$11.3M Hold
77,719
– – 77.07% 1
2021
Q2 		$47.6M Hold
77,719
– – 92% 1
2021
Q1 		$54.4M Hold
77,719
– – 59.34% 1
2020
Q4 		$58.5M Buy
+77,719
New +$54.3M 50.97% 1

ABG-WTT Global Life Science Capital Partners's MDVL Position: Q1 2024 in Review

ABG-WTT Global Life Science Capital Partners sold out of MedAvail Holdings, Inc. Common Stock (MDVL) in Q1 2024, closing a stake of 300,588 shares — an estimated $1.35M sold.

ABG-WTT Global Life Science Capital Partners first reported a position in MDVL in Q4 2020 and held it in 13 quarters. The position peaked at $58.5M in Q4 2020. 1 fund tracked by Wall St. Rank holds MDVL as of Q1 2024.

  • ABG-WTT Global Life Science Capital Partners reported no remaining MedAvail Holdings, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • ABG-WTT Global Life Science Capital Partners sold 300,588 MedAvail Holdings, Inc. Common Stock shares in Q1 2024, an estimated $1.35M.
  • ABG-WTT Global Life Science Capital Partners first reported a position in MedAvail Holdings, Inc. Common Stock in Q4 2020 and held it in 13 quarters.
  • ABG-WTT Global Life Science Capital Partners's MedAvail Holdings, Inc. Common Stock position peaked at $58.5M in Q4 2020.
  • 1 fund tracked by Wall St. Rank held MedAvail Holdings, Inc. Common Stock as of Q1 2024.

Based on ABG-WTT Global Life Science Capital Partners's 13F filing for Q1 2024, filed 15 May 2024.